7 research outputs found
Aggregation time course of HTT<sup>NT</sup>Q<sub>37</sub>P<sub>10</sub>C*K<sub>2</sub> by EM and FCS.
<p>Aggregation time course of HTT<sup>NT</sup>Q<sub>37</sub>P<sub>10</sub>C*K<sub>2</sub> by EM and FCS.</p
Structures and assembly mechanism of HTT exon1 polypeptides.
<p>A. Previously proposed mechanism of amyloid nucleation (HTT<sup>NT</sup>, green; polyQ, orange; PRD, black). B. Sequence of HTT exon1. C. Sequences of peptides studied. C* = Cys residue modified with Alexa Fluor 555 (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155747#sec009" target="_blank">Materials and Methods</a>).</p
Summary of FCS data showing molecular sizes under various conditions.
<p>Summary of FCS data showing molecular sizes under various conditions.</p
Self-assembly of full length HTT exon1-EGFP fusions in PC12 living cells and cell extracts.
<p>A. Raw FCS data from clarified native lysates of PC12 cells after different growth times. B. Autocorrelation functions with residuals of 24 hrs clarified native lysates of cells producing GFP alone (green) or HTT exon1-Q<sub>25</sub>-EGFP (black). C. Autocorrelation functions with residuals of native lysate supernatants of PC12 cells producing HTT exon1-Q<sub>97</sub>-EGFP at different growth times (color code as in part A). D, E. Autocorrelation functions with residuals of data collected from the cytoplasm of living PC12 cells producing either HTT exon1-Q<sub>25</sub>-EGFP (D) or HTT exon1-Q<sub>97</sub>-EGFP (E).</p
Characteristics of the PC12 model.
<p>A. Confocal microscopy of the Q25 and Q97 versions of HTT exon1 after 6 and 24 hrs growth in the presence of 1 μM ponesterone. Blue = Hoechst dye stained nucleus; green = EGFP. B. Number of cells containing inclusions at different growth times determined by fluorescence microscopy. C. Percent cell death at different growth times as determined by the amount of the intracellular enzyme lactate dehydrogenase released into the medium, an indication of the loss of outer cell membrane integrity.</p
Self-assembly in PBS of chemically synthesized HTT exon1 analogs.
<p>A. Raw FCS time-dependent fluorescence fluctuations of HTT<sup>NT</sup>Q<sub>23</sub>P<sub>10</sub>C*K<sub>2</sub> (red) and HTT<sup>NT</sup>Q<sub>37</sub>P<sub>10</sub>C*K<sub>2</sub> (black). B. Autocorrelation functions for the 10 mins FCS data shown in A, with the data points as filled squares and solid lines representing the fits (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155747#sec009" target="_blank">Materials and Methods</a>) and the same color scheme as A. Lines below the graph show the residuals between the data points and the fit curve. C. Concentration dependence of molecular size estimated from diffusion times for HTT<sup>NT</sup>Q<sub>37</sub>P<sub>10</sub>C*K<sub>2</sub> (■) and HTT<sup>NT</sup>Q<sub>23</sub>P<sub>10</sub>C*K<sub>2</sub> (). D. EM detail of different time points from the PBS incubation of a mixture of 2.0 μM HTT<sup>NT</sup>Q<sub>37</sub>P<sub>10</sub>K<sub>2</sub>. (More EM data is shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0155747#pone.0155747.s001" target="_blank">S1 Fig</a>.)</p
Kinetically Competing Huntingtin Aggregation Pathways Control Amyloid Polymorphism and Properties
In polyglutamine (polyQ) containing fragments of the
Huntington’s disease protein huntingtin (htt), the N-terminal
17 amino acid htt<sup>NT</sup> segment serves as the core of α-helical
oligomers whose reversible assembly locally concentrates the polyQ
segments, thereby facilitating polyQ amyloid nucleation. A variety
of aggregation inhibitors have been described that achieve their effects
by neutralizing this concentrating function of the htt<sup>NT</sup> segment. In this paper we characterize the nature and limits of
this inhibition for three means of suppressing htt<sup>NT</sup>-mediated
aggregation. We show that the previously described action of htt<sup>NT</sup> peptide-based inhibitors is solely due to their ability
to suppress the htt<sup>NT</sup>-mediated aggregation pathway. That
is, under htt<sup>NT</sup> inhibition, nucleation of polyQ amyloid
formation by a previously described alternative nucleation mechanism
proceeds unabated and transiently dominates the aggregation process.
Removal of the bulk of the htt<sup>NT</sup> segment by proteolysis
or mutagenesis also blocks the htt<sup>NT</sup>-mediated pathway,
allowing the alternative nucleation pathway to dominate. In contrast,
the previously described immunoglobulin-based inhibitor, the antihtt<sup>NT</sup> V<sub>L</sub> 12.3 protein, effectively blocks both amyloid
pathways, leading to stable accumulation of nonamyloid oligomers.
These data show that the htt<sup>NT</sup>-dependent and -independent
pathways of amyloid nucleation in polyQ-containing htt fragments are
in direct kinetic competition. The results illustrate how amyloid
polymorphism depends on assembly mechanism and kinetics and have implications
for how the intracellular environment can influence aggregation pathways